SCHEMBL4124280

SCHEMBL4124280

COc1cccc(C(=O)c2cc(C)ccc2N)c1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
NPC1 O15118 5/20 0.48
MAPT P10636 2/20 0.48
MAPK1 P28482 2/20 0.48
HTT P42858 1/20 0.48
GAA P10253 4/20 0.46
HSD17B10 Q99714 3/20 0.46
KMT2A Q03164 2/20 0.46
RAB9A P51151 4/20 0.46
ALDH1A1 P00352 3/20 0.46
CBX7 O95931 3/20 0.46
TP53 P04637 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
KDM4E B2RXH2 2/20 0.45
LMNA P02545 2/20 0.45
ALOX15 P16050 1/20 0.44
IDO1 P14902 1/20 0.44
TDO2 P48775 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1340512 0.88 LMNA (0.55) L3MBTL1NPC1MAPTMAPK1HTT
SCHEMBL4111182 0.86 MAPK14 (0.49) ATML3MBTL1NPC1GAAHSD17B10
SCHEMBL4128972 0.84 TP53 (0.47) NPC1MAPTMAPK1HTTGAA
SCHEMBL4117593 0.84 MAPT (0.50) L3MBTL1NPC1MAPTMAPK1HTT
SCHEMBL635552 0.84 RECQL (0.56) NPC1GAAHSD17B10KMT2ARAB9A
SCHEMBL3762150 0.83 RAB9A (0.55) ATML3MBTL1NPC1MAPTMAPK1
SCHEMBL8467508 0.81 RAB9A (0.52) ATML3MBTL1NPC1MAPTMAPK1
SCHEMBL13775820 0.81 RORB (0.48) L3MBTL1MAPTGAAHSD17B10KMT2A
SCHEMBL12116692 0.81 TUBB4A (0.60) NPC1MAPTMAPK1HTT
SCHEMBL4118069 0.79 MAPK14 (0.51) ATML3MBTL1NPC1GAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR ATM 2628/4885L3MBTL1 661/4885NPC1 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.